Biologics and Personalized Medicine in Severe Asthma: One Step at a Time

Affiliations

¹ Medical Research Institute of New Zealand, Wellington, New Zealand. Electronic address: Richard.Beasley@mrinz.ac.nz.
² Medical Research Institute of New Zealand, Wellington, New Zealand.

Editorial

Richard Beasley et al. J Allergy Clin Immunol Pract. 2023 Jun.

. 2023 Jun;11(6):1771-1772.

doi: 10.1016/j.jaip.2023.04.022.

¹ Medical Research Institute of New Zealand, Wellington, New Zealand. Electronic address: Richard.Beasley@mrinz.ac.nz.
² Medical Research Institute of New Zealand, Wellington, New Zealand.

No abstract available

Comment on

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488